Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

352 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Monoclonal Antibody Against Mature Interleukin-18 Ameliorates Colitis in Mice and Improves Epithelial Barrier Function.
Ikegami S, Maeda K, Urano T, Mu J, Nakamura M, Yamamura T, Sawada T, Ishikawa E, Yamamoto K, Muto H, Oishi A, Iida T, Mizutani Y, Ishikawa T, Kakushima N, Furukawa K, Ohno E, Honda T, Ishigami M, Kawashima H. Ikegami S, et al. Among authors: muto h. Inflamm Bowel Dis. 2024 Aug 1;30(8):1353-1366. doi: 10.1093/ibd/izad292. Inflamm Bowel Dis. 2024. PMID: 38141180
A new criterion including the aspartate aminotransferase-to-platelet ratio index and liver and spleen stiffness to rule out varices needing treatment in children with biliary atresia: Modification of the Baveno VII criteria.
Yokoyama S, Ishizu Y, Honda T, Imai N, Ito T, Yamamoto K, Muto H, Shirota C, Tainaka T, Sumida W, Makita S, Takada S, Nakagawa Y, Maeda T, Nakamura M, Ishigami M, Uchida H, Kawashima H. Yokoyama S, et al. Among authors: muto h. Hepatol Res. 2024 Apr;54(4):347-357. doi: 10.1111/hepr.13976. Epub 2023 Oct 25. Hepatol Res. 2024. PMID: 37843392
Early Changes in Alpha-Fetoprotein and Des-γ-Carboxy Prothrombin Are Useful Predictors of Antitumor Response to Durvalumab Plus Tremelimumab Therapy for Advanced Hepatocellular Carcinoma.
Kuzuya T, Kawabe N, Muto H, Wada Y, Komura G, Nakano T, Tanaka H, Nakaoka K, Ohno E, Funasaka K, Nagasaka M, Miyahara R, Hirooka Y. Kuzuya T, et al. Among authors: muto h. Curr Oncol. 2024 Jul 26;31(8):4225-4240. doi: 10.3390/curroncol31080315. Curr Oncol. 2024. PMID: 39195298 Free PMC article.
Characteristics and Prognosis of Patients with Advanced Hepatocellular Carcinoma Treated with Atezolizumab/Bevacizumab Combination Therapy Who Achieved Complete Response.
Kuzuya T, Kawabe N, Muto H, Tachi Y, Ukai T, Wada Y, Komura G, Nakano T, Tanaka H, Nakaoka K, Ohno E, Funasaka K, Nagasaka M, Miyahara R, Hirooka Y. Kuzuya T, et al. Among authors: muto h. Curr Oncol. 2024 Oct 16;31(10):6218-6231. doi: 10.3390/curroncol31100463. Curr Oncol. 2024. PMID: 39451767 Free PMC article.
Stress-Induced Martensitic Transformation in Na3YCl6.
Miura A, Muraoka K, Maki K, Kawaguchi S, Hikima K, Muto H, Matsuda A, Yamane I, Shimada T, Ito H, Mizuguchi Y, Moriyoshi C, Nakajima H, Mori S, Oike H, Nakayama A, Sun W, Rosero-Navarro NC, Tadanaga K. Miura A, et al. Among authors: muto h. J Am Chem Soc. 2024 Sep 11;146(36):25263-25269. doi: 10.1021/jacs.4c09476. Epub 2024 Sep 1. J Am Chem Soc. 2024. PMID: 39219155
352 results